GlobalData

Three big ticket deals contribute 74 per cent of total deal value in Feb 2021

COVID-19 uncovered a strong need for innovation and the adoption of digital tools, and quite successfully showcased how quickly…

The Central Drugs Standard Control Organization (CDSCO) has recently approved several generic versions of sunitinib to treat…

Cabotegravir-based therapies are projected to generate 79 per cent of the sales of injectable therapeutics in the HIV market in…

The UK-EU trade deal will give the UK researchers and businesses access to Horizon Europe funding on equivalent terms as EU…

Experts estimate that achieving herd immunity to COVID-19 will required upwards of 70–90 per cent of the population to have…

GlobalData expects that the low cost of the AstraZeneca/Oxford vaccine will allow it to be used in low-income countries – where…

In India, the current rate of new cases is 10 per one million population, in marked contrast to the US, where the rate is 370 new…

The largest proportion of the ongoing vaccine trials are now in Phase II (38.6 per cent) and Phase III (36.3 per cent), after…

As countries increasingly have weapons against COVID-19 in their armamentarium, increased scrutiny will be placed on the fifth,…